Current-season preparedness starts with ACIP/WHO strain review, a full formulary inventory (IIV3, HD-IIV3, aIIV3, RIV3, LAIV3), and integration of any 65+ preferential recommendations.
Screening and counseling workflows should reflect updated contraindications/precautions, coadministration practices, and patient education on end-of-October timing, annual vaccination, and expected effectiveness.
Competency standards include state-valid immunization certification, annual administration refresher (IM and intranasal), anaphylaxis drills, current BLS/CPR, and VAERS reporting responsibilities.
Procurement planning should forecast demand by demographics and formulation, secure allocations with contingencies, purchase pediatric presentations, and stock needles/supplies with a 10%–15% buffer plus current VIS access.
Cold-chain, billing, and operations require 2–8 °C monitored storage, lot/expiry logging and FIFO, excursion segregation procedures, updated CPT/product codes, payer verification, and efficient high-volume clinic flow with epinephrine stocked.
SHOW MORE
Prepare your pharmacy for flu season with updated vaccine formulations, screening, staffing, ordering, cold-chain controls, billing workflows, and patient outreach to boost vaccination uptake.
Advertisement
Clinical Preparedness
Strain and Formulation Review
Review CDC Advisory Committee on Immunization Practices (ACIP) and World Health Organization recommendations for the current season’s circulating strains.
Identify all available formulations: standard-dose trivalent inactivated influenza vaccine (IIV3); HD-IIV3 (Fluzone HD; Sanofi); aIIV3 (Fluad; CSL Seqirus); recombinant influenza vaccine, trivalent (Flublok; Sanofi); and trivalent live attenuated influenza vaccine (LAIV3, FluMist; MedImmune, LLC).
Note any new ACIP preferential recommendations by age group (eg, high-dose or adjuvanted preferred for individuals 65 years and older).
Review FDA-approved product changes and updated package inserts for this season.
Screening and Counseling
Update screening questionnaires to reflect current contraindications and precautions.
Confirm coadministration protocols.
Refresh patient counseling points: timing (by the end of October), annual need, and expected effectiveness.
Staff Competency
Verify that all vaccinating staff hold current, state-valid immunization certification.
Conduct an annual refresher on injection technique, LAIV nasal administration, and anaphylaxis response.
Confirm basic life support/cardiopulmonary resuscitation certification is current, and review Vaccine Adverse Event Reporting System reporting responsibilities.
Ordering & Procurement
Analyze data from the prior 2 seasons to forecast demand by formulation and patient demographics.
Contact wholesalers and manufacturers to secure allocation.
Confirm ordering windows and deadlines, and identify a backup supplier in case of shortage or recall.
Order all required formulations, including pediatric presentations. Document purchase orders with expected delivery dates.
Stock ancillary supplies: 22g-25g needles (1”-1.5”), syringes, alcohol swabs, and bandages. Add a 10% to 15% buffer over prior-season quantities.
Obtain current-edition Vaccine Information Statements or confirm your electronic health record (EHR) delivers the current version at the point of care.
Storage and Cold Chain
Inspect and service refrigeration units. Confirm the temperature is maintained at 2 °C to 8 °C using a calibrated data logger.
Test continuous monitoring alarms and verify that after-hours alert contacts are up to date.
Confirm backup power covers refrigeration, and document emergency transfer protocol to a partner pharmacy.
Designate a trained staff member to receive shipments: Check temperature indicators, vial integrity, and documentation before accepting.
Log lot numbers, expiration dates, and quantities for every delivery, and implement first-in, first-out rotation.
Review the vaccine temperature excursion standard of practice. Segregate but do not discard the affected product before contacting the manufacturer or state health department.
For LAIV, store refrigerated, not frozen. Do not refreeze once removed from cold storage.
Regulatory, Billing, and Documentation
Confirm immunization scope of practice for pharmacists and technicians under current state law.
Renew standing orders or collaborative practice agreements before the season begins.
Verify malpractice coverage includes vaccine administration; confirm applicable Public Readiness and Emergency Preparedness Act protections.
Update current procedural terminology and vaccine-administered codes in your practice management system/EHR for all flu products. Codes change annually.
Confirm Medicare Part B billing (no deductible/co-pay for beneficiaries); verify Medicaid and commercial coverage for each formulation.
Update self-pay pricing; confirm 340B segregation and documentation if applicable.
Test EHR workflow end-to-end: lot number capture, consent documentation (include the vaccine information statement publication date), and state immunization information system transmission.
Operations and Patient Experience
Streamline vaccination workflow, including a dedicated queue, injection station, and 15-minute postvaccination observation seating.
Set staffing plan for peak demand (September-November) and identify all certified immunizers on staff.
Update the pharmacy’s website, Google Business Profile, and social media with formulations offered, hours, and walk-in/appointment policy.
Activate patient outreach with automated reminders for high-risk groups (adults 65 years or older, pregnant patients, children aged 6 months to 5 years, and immunocompromised).
Pursue on-site clinic opportunities with employers, senior centers, and schools; begin outreach by August.
Confirm epinephrine auto-injectors (≥ 2, nonexpired) are stocked at every vaccination station. Post emergency protocol and contacts.
Review sharps/needlestick injury protocol, and ensure sharps containers are at all points of care.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
A year after FDA approval in heart failure (HF) with LVEF of 40% or higher, new ACC guidance and trial subanalyses are shaping how pharmacists use finerenone.